Management of acute spinal cord compression in multiple myeloma

被引：9
作者：
Chen, Bo [1 ]
Cai, Lin [2 ]
Zhou, Fuling [1 ]
机构：
[1] Wuhan Univ, Zhongnan Hosp, Dept Hematol, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China
[2] Wuhan Univ, Dept Orthoped, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2021年 / 160卷
关键词：
Multiple myeloma; Spinal cord compression; Anti-plasma cell therapies; Radiation therapy; Surgery; POSITRON-EMISSION-TOMOGRAPHY; BONE-DISEASE; RADIATION-THERAPY; METASTATIC TUMOR; ZOLEDRONIC ACID; DIAGNOSIS; EXTRAMEDULLARY; DEXAMETHASONE; KYPHOPLASTY; BORTEZOMIB;
D O I：
10.1016/j.critrevonc.2020.103205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Spinal cord compression (SCC) is a devastating complication of multiple myeloma and has the potential to cause loss of neurological function. The common symptoms of SCC are back pain, motor weakness, and sensory change. Once diagnosed, the patient should be managed as soon as possible to prevent permanent loss of neurological function. Currently, there have been a number of studies describing the mechanism and management experience of SCC in patients with myeloma. The clinical features, diagnostic strategies, and the roles of different therapeutic options are herein reviewed.
引用
收藏
页数：7
相关论文
共 91 条
  • [51] First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
    Morgan, Gareth J.
    Davies, Faith E.
    Gregory, Walter M.
    Cocks, Kim
    Bell, Sue E.
    Szubert, Alex J.
    Navarro-Coy, Nuria
    Drayson, Mark T.
    Owen, Roger G.
    Feyler, Sylvia
    Ashcroft, A. John
    Ross, Fiona
    Byrne, Jennifer
    Roddie, Huw
    Rudin, Claudius
    Cook, Gordon
    Jackson, Graham H.
    Child, J. Anthony
    [J]. LANCET, 2010, 376 (9757) : 1989 - 1999
  • [52] Bisphosphonates as anticancer drugs
    Mundy, GR
    Yoneda, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (06) : 398 - 400
  • [53] A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma
    Musto, Pellegrino
    Petrucci, Maria Teresa
    Bringhen, Sara
    Guglielmelli, Tommasina
    Caravita, Tommaso
    Bongarzoni, Velia
    Andriani, Alessandro
    D'Arena, Giovanni
    Balleari, Enrico
    Pietrantuono, Giuseppe
    Boccadoro, Mario
    Palumbo, Antonio
    [J]. CANCER, 2008, 113 (07) : 1588 - 1595
  • [54] National Collaborating Centre for Cancer (UK),, 2008, METASTATIC SPINAL CO
  • [55] O'Donnell EK, 2017, CLIN ADV HEMATOL ONC, V15, P285
  • [56] MEDICAL PROGRESS Multiple Myeloma
    Palumbo, Antonio
    Anderson, Kenneth
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (11) : 1046 - 1060
  • [57] Myeloma and Bone Disease
    Panaroni, Cristina
    Yee, Andrew J.
    Raje, Noopur S.
    [J]. CURRENT OSTEOPOROSIS REPORTS, 2017, 15 (05) : 483 - 498
  • [58] Comparing effects of kyphoplasty, vertebroplasty, and non-surgical management in a systematic review of randomized and non-randomized controlled studies
    Papanastassiou, Ioannis D.
    Phillips, Frank M.
    Van Meirhaeghe, Jan
    Berenson, James R.
    Andersson, Gunnar B. J.
    Chung, Gary
    Small, Brent J.
    Aghayev, Kamran
    Vrionis, Frank D.
    [J]. EUROPEAN SPINE JOURNAL, 2012, 21 (09) : 1826 - 1843
  • [59] Papavassiliou E, 1997, J NEUROSCI RES, V49, P451, DOI 10.1002/(SICI)1097-4547(19970815)49:4<451::AID-JNR6>3.0.CO
  • [60] 2-7
12345678910